Core Viewpoint - Chengdu Xian Dao has signed a new collaboration agreement with the Gates Foundation to utilize its DNA-encoded library (DEL) technology platform for drug discovery targeting unmet medical needs such as tuberculosis and malaria, as well as novel non-hormonal contraceptives [1] Group 1 - Chengdu Xian Dao will screen new lead compounds for 15 drug targets identified in collaboration with the Gates Foundation and its academic and research partners [1] - The drug discovery efforts will receive funding support from the Gates Foundation [1]